Skip to main content
Clinical Trials/CTRI/2026/02/102761
CTRI/2026/02/102761
Not yet recruiting
Phase 2/3

A prospective randomized comparative study of dexamethasone versus magnesium sulphate as an adjuvant to ropivacaine in ilioinguinal iliohypogastric block in lower abdominal surgeries under general anaesthesia.

LLRM Medical College1 site in 1 country80 target enrollmentStarted: February 10, 2026Last updated:

Overview

Phase
Phase 2/3
Status
Not yet recruiting
Sponsor
LLRM Medical College
Enrollment
80
Locations
1
Primary Endpoint
To evaluate and compare the efficacy and the

Overview

Brief Summary

This is a prospective randomised comparative evaluation of postoperative analgesia achieved with Ilioinguinal Iliohypogastric block using Ropivacaine with Dexamethasone versus Ropivacaine with Magnesium Sulphate in lower abdominal surgeries performed under general anaesthesia.

Also will be assessing the timing of requiring first dose of rescue analgesic, total dose of rescue analgesia required in 24 hours, hemodynamic changes, Quality of Recovery Score assessment and complications if any during post operative period.

Study Design

Study Type
Interventional
Allocation
Other
Masking
Participant and Investigator Blinded

Eligibility Criteria

Ages
18.00 Year(s) to 65.00 Year(s) (—)
Sex
All

Inclusion Criteria

  • ASA Grade 1 And 2 Age 18-65 Yrs Sex Male and Female BMI 18 to 25 kg per sq metre Patients Undergoing lower abdominal surgeries under General Anaesthesia Patients with informed consent.

Exclusion Criteria

  • Patient refusal Infection at injection site Coagulopathy Significant cardiopulmonary diseases, hepatic and renal dysfunction Chronic alcohol or narcotic drug abuse Peripheral neuropathy Known allergy or hypersensitivity to study drug.

Outcomes

Primary Outcomes

To evaluate and compare the efficacy and the

Time Frame: Postoperatively pain will be assessed at different | time intervals for initial 24 hrs

quality of post operative analgesia.

Time Frame: Postoperatively pain will be assessed at different | time intervals for initial 24 hrs

Secondary Outcomes

  • Timing of requiring first dose of rescue analgesic(Patient to be assessed for 24 hours post)
  • Total analgesic consumption in 24 hours(Patient to be assessed for 24 hours post)
  • Assess hemodynamic changes(Patient to be assessed for 24 hours post)
  • Post operative Quality of Recovery Score(Patient to be assessed for 24 hours post)

Investigators

Sponsor
LLRM Medical College
Sponsor Class
Government medical college
Responsible Party
Principal Investigator
Principal Investigator

Dr Shivangi Gupta

Lala Lajpat Rai Memorial Medical College Meerut

Study Sites (1)

Loading locations...

Similar Trials